Gu Fangzhou's work has significantly improved the effectiveness of polio attenuated vaccine and protected millions of children from the threat of polio. As a pioneer in the development of China's oral attenuated vaccine through cell culture, Gu's journey into public health and virology is explored in this paper. The reasons behind Gu's pursuit of a career in public health and virology are introduced and the process of developing China's first batches of attenuated polio vaccines is detailed. Furthermore, the factors influencing the choice of technical routes for polio vaccine development is discussed, as well as the processes and results of vaccine production, verification, and clinical trials. Gu has closely linked his personal destiny with the future of the nation. His research and efforts have significantly improved the health and quality of life for hundreds of millions of people.
ZUO Kunlan
,
HUANG Jianliang
,
SUN Bo
,
LIU Huan
. “People's Scientist” Gu Fangzhou: A pioneer of polio eradication in China[J]. Science & Technology Review, 2024
, 42(19)
: 119
-127
.
DOI: 10.3981/j.issn.1000-7857.2024.01.00113
[1] 黄兴力. 宁波帮与近现代中国教育业[M]. 宁波: 宁波出版社, 2021: 340-346.
[2] 徐源. 使命的召唤: 顾方舟传[M]. 南京: 江苏人民出版社, 2016.
[3] 顾方舟, 范瑞婷. 一生一事顾方舟口述史[M]. 北京: 商务印书馆, 2018.
[4] Rosen F S. Isolation of poliovirus: John enders and the Nobel prize[J]. The New England Journal of Medicine, 2004, 351(15): 1481-1483.
[5] 刘悦越, 赵荣荣, 李长贵. 脊髓灰质炎疫苗的研究进展[J]. 中国生物制品学杂志, 2021, 34(12): 1506-1510.
[6] 顾方舟. 脊髓灰质炎[M]. 上海: 上海科学技术出版社, 1984: 240-280.
[7] De Jesus N H. Epidemics to eradication: The modern history of poliomyelitis[J]. Virology Journal, 2007, 44(1): 1-18.
[8] 张文宏, 王新宇, 褚君浩. 疫苗简史[M]. 上海: 上海教育出版社, 2021: 61-68.
[9] Landsteiner K. Ubertragung der Poliomyelitis acuta auf Affen[J]. Z Immunitatsforsch, 1909, 2: 377-390.
[10] Paul J R, Trask J D. The detection of poliomyelitis virus in so called abortive types of the disease[J]. The Journal of Experimental Medicine, 1932, 56(3): 319-343.
[11] Baicus A. History of polio vaccination[J]. World Journal of Virology, 2012, 1(4): 108-114.
[12] Dulbecco R, Vogt M. Plaque formation and isolation of pure lines with poliomyelitis viruses[J]. The Journal of Experimental Medicine, 1954, 99(2): 167-182.
[13] 王季午, 吴朝仁, 钱德, 等. 高等医药院校试用教材传 染病学[M]. 北京: 人民卫生出版社, 1959: 71-78.
[14] 慕景强. 之江水蕴：且凭杏实访民国[M]. 杭州: 浙江工商大学出版社, 2014: 57-60.
[15] Melnick J L. Advantages and disadvantages of killed and live poliomyelitis vaccines[J]. Bulletin of the World Health Organization, 1978, 56(1): 21-38.
[16] 顾方舟. 小儿麻痹减毒减毒疫苗的目前状况与前景[J]. 中华儿科杂志, 1959, 10(6): 455.
[17] 顾方舟. 关于使用脊髓灰质炎减毒疫苗若干问题[J]. 中级医刊, 1979(1): 1-3.
[18] Centers for Disease Control and Prevention (CDC). Progress toward global eradication of poliomyelitis, 1988-1993[J]. MMWR Morbidity and Mortality Weekly Report, 1994, 43(27): 499-503.
[19] 刘阳, 顾方舟. 脊髓灰质炎病毒的变异性与鉴别研究[J]. 国外医学生物制品分册, 1984(4): 150-153.
[20] 顾方舟, 范瑞婷. 脊髓灰质炎疫苗的研究——顾方舟访谈[J]. 中华医史杂志, 2018, 48(5): 304-312.
[21] 李立明. 协和硕果: 中国医学科学院北京协和医学院成就荟萃[M]. 北京: 中国协和医科大学出版社, 2009: 255-263.
[22] 顾方舟, 王政. 口服脊髓灰质炎减毒疫苗儿童免疫力维持时间的研究[J]. 微生物学报, 1965, 11(3): 305-310.
[23] 顾方舟教授寿辰庆祝文编写组. 使命与奉献——记“中国脊髓灰质炎疫苗之父”顾方舟教授[J]. 生物工程学报, 2012, 28(3): 376-382.
[24] 金萍. 天光云影共徘徊——记病毒学专家顾方舟夫妇[J]. 国际人才交流, 1995(11): 21-25.
[25] 彭小忠, 顾方舟. 中国的脊灰消灭与脊灰病毒新型疫苗、抗脊灰病毒药物的研发和应用[C]//中国科协年会论文集（第13分会场）, 北京: 中国高科技产业化研究会, 2006: 2.
[26] 国家卫生健康委员会（原国家卫生和计划生育委员会）. 我国响应世卫组织决议实施脊灰疫苗免疫新策略[EB/OL].（2016-04-29）[2024-04-14]. http://www.nhfpc.gov.cn/jkj/s3582/201604/8c760a934d5b4d41a81752915-c58d304.shtml.
[27] 中国科学技术协会. 见证百年的科学经典[M]. 北京: 中国科学技术出版社, 2021: 113-115.
